This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated CEBPD Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CEBPD WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~28.5 kDa | |
| Observed band | ~36 kDa | |
| Gel | 12–15% | |
| Negative control | siRNA / KO lysate |
| PTM | Acetylated + Ubiquitinated | |
| Caveat | Ubiquitin conjugation | |
| Regulation | TNFα up | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for CEBPD — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human A549 , Lane 2: human placenta , Lane 3: human U87 , Lane 4: mouse RAW264.7 . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-CEBP Delta/CEBPD antigen affinity purified polyclonal antibody (Catalog # A03499-4) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for CEBP Delta/CEBPD at approximately 36KD. The expected band size for CEBP Delta/CEBPD is at 36KD |
| Gel % | 12–15% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 36 kDa |
CEBPD's 28.5 kDa calculated mass runs empirically at ~36 kDa on Western blot, a shift not attributable to glycosylation, cleavage, or disulfide bonds, possibly reflecting residual dimer complexes.
| single band around 36 kDa | full-length CEBPD monomer, migrating above its 28.5 kDa calculated mass on SDS-PAGE |
| no additional bands from alternative splicing | UniProt annotates only one CEBPD isoform, so extra bands are not expected from splice variants |
| no lower-molecular-weight cleaved fragment | CEBPD has no annotated signal peptide or propeptide, so the full-length protein is detected without a smaller mature form |
| no glycosylation-associated smear or upward shift | CEBPD has zero annotated glycosylation sites, so mobility differences are not caused by glycan heterogeneity |
| faint higher-molecular-weight species near double the monomer mass | may reflect homodimer or CEBPB/CEBPA/CEBPE heterodimer complexes formed through the annotated DNA-binding dimerization interface, most apparent under incomplete denaturation |
| predicted mass (28.5 kDa, 269 aa) | baseline calculated mass from the sequence before any modification or migration effects |
| empirical observed band (~36 kDa) | the actual apparent molecular weight seen on reducing SDS-PAGE, roughly 7.5 kDa above the calculated mass |
| N-terminal acetylation (N-acetylserine, position 2) | minor covalent modification adding negligible mass, not sufficient to account for the observed size shift |
| homodimer/heterodimer formation (with CEBPB, CEBPA, CEBPE) | non-covalent dimerization through the DNA-binding interface can produce a higher-molecular-weight species near twice the monomer mass if dimers are not fully dissociated before loading |
| single annotated isoform | no alternative splice forms are expected to generate additional bands |
| absence of signal peptide or propeptide | no proteolytic maturation step, so no smaller cleaved fragment is expected below the full-length band |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | CEBPD consistently migrates above its 28.5 kDa calculated mass, appearing near 36 kDa, and residual homodimer/heterodimer complexes can add a further higher-molecular-weight species | confirm the band matches the ~36 kDa observed size, use fully reducing/denaturing sample buffer, and boil samples longer to dissociate residual dimer |
| No band in lysate | CEBPD is a nuclear transcription factor, so standard whole-cell lysis protocols that under-extract nuclear proteins can yield insufficient signal | use a nuclear extraction or high-salt lysis buffer with adequate sonication to ensure nuclear protein solubilization before loading |
| Multiple bands | co-migrating CEBPB, CEBPA, or CEBPE heterodimer partners, or antibody cross-reactivity with related CEBP family members, can appear as extra bands | include positive and negative control lysates and compare against the known ~36 kDa CEBPD band to distinguish specific signal from cross-reactivity |
| Band lower than expected | with no annotated cleavage site, a lower band most likely reflects proteolytic degradation during lysate preparation rather than natural processing | add fresh protease inhibitors and keep samples cold throughout lysis and handling to minimize degradation |
| Weak or no signal | CEBPD is an inducible transcription factor expressed at low basal levels in many unstimulated cell types | use a stimulus known to induce CEBPD expression and load sufficient nuclear protein per lane to boost detectable signal |
| Fragments below expected size | non-specific proteolysis during extraction can generate faster-migrating fragments even though no natural cleavage step is annotated | use a fresh protease inhibitor cocktail and minimize freeze-thaw cycles of lysates before loading |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for CEBPD, answered from its protein features.
BosterBio's CEBPD antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
For CEBPD detection, Boster's A03499-4 anti-CEBP Delta antibody stands out as the top-performing choice, backed by extensive citation history and rigorous validation, including confirmed specificity in western blot with orthogonal cross-checks against negative tissue controls and complementary detection methods for reliable, reproducible results.
Which to pick: Only one CEBPD antibody is catalogued here: A03499-4. It comes with an actual western blot validation image (SDS-PAGE, 5-20% gel), making it the clear default pick for your CEBPD WB experiments since no alternative SKUs are currently listed.